Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.062 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |